Literature DB >> 12475231

Lysine 152 of MuLV reverse transcriptase is required for the integrity of the active site.

Qingli Shi1, Kamalendra Singh, Aashish Srivastava, Neerja Kaushik, Mukund J Modak.   

Abstract

Comparison of the three-dimensional structure of the active sites of MuLV and HIV-1 reverse transcriptases shows the presence of a lysine residue (K152) in the substrate-binding region in MuLV RT, while its equivalent position in HIV-1 RT is occupied by a glycine (G112). To investigate the role of K152 in the mechanism of the polymerase reaction catalyzed by MuLV RT, four mutant RTs, namely, K152A, K152R, K152E, and K152G, were generated and biochemically characterized. All muteins exhibited reduced polymerase activity on both RNA and DNA template-primers with K152E being the most defective. The template-primer binding affinity and the processivity of DNA synthesis, however, remained unchanged. The steady-state kinetic characterization showed little change in K(m.dNTP) (except for that of K152E) and an approximately 3-10-fold decrease in k(cat) depending upon the template-primer and mutational substitutions. The ddNTP resistance patterns were unchanged for all muteins, suggesting no participation of K152 in ddNTP recognition. The ability of individual muteins to add dNTP on the covalently cross-linked enzyme-template-primer complex was significantly decreased. These results together with the analysis of the ion pairs in the catalytic apparatus of MuLV RT suggest that K152 participates in maintaining the integrity of the active site of MuLV RT. Examination of the prepolymerase ternary complex formation showed that neither the wild type nor any of the K152 muteins of MuLV RT are capable of forming stable ternary complexes. This property is in contrast to that of HIV-1 RT, which readily forms stable ternary complexes under similar conditions. These results further indicate that the catalytic mechanism of MuLV RT is significantly different from that of HIV-1 RT, despite the presence of a number of conserved motifs and amino acid residues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12475231     DOI: 10.1021/bi0258389

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  The reverse transcriptase encoded by the non-LTR retrotransposon R2 is as error-prone as that encoded by HIV-1.

Authors:  Varuni K Jamburuthugoda; Thomas H Eickbush
Journal:  J Mol Biol       Date:  2011-02-12       Impact factor: 5.469

2.  Mechanistic differences in RNA-dependent DNA polymerization and fidelity between murine leukemia virus and HIV-1 reverse transcriptases.

Authors:  Mark Skasko; Kellie K Weiss; Holly M Reynolds; Varuni Jamburuthugoda; Kwi Lee; Baek Kim
Journal:  J Biol Chem       Date:  2005-01-10       Impact factor: 5.157

3.  SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates.

Authors:  Hichem Lahouassa; Waaqo Daddacha; Henning Hofmann; Diana Ayinde; Eric C Logue; Loïc Dragin; Nicolin Bloch; Claire Maudet; Matthieu Bertrand; Thomas Gramberg; Gianfranco Pancino; Stéphane Priet; Bruno Canard; Nadine Laguette; Monsef Benkirane; Catherine Transy; Nathaniel R Landau; Baek Kim; Florence Margottin-Goguet
Journal:  Nat Immunol       Date:  2012-02-12       Impact factor: 25.606

4.  Pausing kinetics dominates strand-displacement polymerization by reverse transcriptase.

Authors:  Omri Malik; Hadeel Khamis; Sergei Rudnizky; Ailie Marx; Ariel Kaplan
Journal:  Nucleic Acids Res       Date:  2017-09-29       Impact factor: 16.971

5.  Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptase.

Authors:  Tanyaradzwa P Ndongwe; Adeyemi O Adedeji; Eleftherios Michailidis; Yee Tsuey Ong; Atsuko Hachiya; Bruno Marchand; Emily M Ryan; Devendra K Rai; Karen A Kirby; Angela S Whatley; Donald H Burke; Marc Johnson; Shilei Ding; Yi-Min Zheng; Shan-Lu Liu; Ei-Ichi Kodama; Krista A Delviks-Frankenberry; Vinay K Pathak; Hiroaki Mitsuya; Michael A Parniak; Kamalendra Singh; Stefan G Sarafianos
Journal:  Nucleic Acids Res       Date:  2011-09-08       Impact factor: 16.971

6.  Functional roles of carboxylate residues comprising the DNA polymerase active site triad of Ty3 reverse transcriptase.

Authors:  Arkadiusz Bibillo; Daniela Lener; George J Klarmann; Stuart F J Le Grice
Journal:  Nucleic Acids Res       Date:  2005-01-12       Impact factor: 16.971

Review 7.  M-MuLV reverse transcriptase: Selected properties and improved mutants.

Authors:  Igor P Oscorbin; Maxim L Filipenko
Journal:  Comput Struct Biotechnol J       Date:  2021-11-22       Impact factor: 7.271

8.  Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors.

Authors:  Neerja Kaushik-Basu; Alain Bopda-Waffo; Tanaji T Talele; Amartya Basu; Paulo R R Costa; Alcides J M da Silva; Stefan G Sarafianos; François Noël
Journal:  Nucleic Acids Res       Date:  2008-01-18       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.